Asklepios Klinik St. Georg — Hamburg

Public research footprint of Asklepios Klinik St. Georg, compiled from the ClinicalTrials.gov public registry.

158

Registered studies

Active

Recruiting now

108

Completed

Stopped or withdrawn

Most-studied conditions

Atrial Fibrillation · Short Bowel Syndrome · Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · Non-Hodgkin's Lymphoma

Recently updated registry entries

NCT07228403 — Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (Active Not Recruiting)
NCT07544654 — DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer… (Recruiting)
NCT04628026 — Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Asklepios Klinik St. Georg?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.